4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001193125-25-313147
PRESIDENT & CEO sold 25,205 shares at an average $45.33 ($1,142,513)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
MORTIMER IAN · PRESIDENT & CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-05 | Sale : show line 1 in the form 10b5-1 | −14,375 | $45.03 | $647,306 | 16,830 | D |
| 2025-12-08 | Sale : show line 2 in the form 10b5-1 | −8,820 | $45.59 | $402,104 | 8,010 | D |
| 2025-12-08 | Sale : show line 3 in the form 10b5-1 | −2,010 | $46.32 | $93,103 | 6,000 | D |
| Open-market sales · 25,205 sh · avg $45.33 · $1,142,513 | ||||||
Loading xslF345X05/ownership.xml…